Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Withdrawn × ficlatuzumab × Clear all

Phase

Status

Completed 3 Terminated 2 Withdrawn 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 CNS 1

Conditions

Gliosarcoma 1 Glioblastoma 1

Interventions

Cyclophosphamide 30 Radiotherapy 21 Cisplatin 21 fludarabine 19 Paclitaxel 17 Nivolumab 16 Magnetic Resonance Spectroscopy 16 Carboplatin 15 pembrolizumab 14 fludarabine phosphate 14 Specimen Handling 13 Gemcitabine 13 Radiation 11 Biopsy 11 Docetaxel 10 Melphalan 9 Filgrastim 9 Etoposide 9 Dexamethasone 9 Cytarabine 9 Radiosurgery 8 Granulocyte Colony-Stimulating Factor 8 Doxorubicin 8 venetoclax 7 trametinib 7 durvalumab 7 Sorafenib 7 Rituximab 7 Pemetrexed 7 Ipilimumab 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01189513 2012-02-20

SCH-900105 in Recurrent Glioblastoma

M.D. Anderson Cancer Center

Phase 1 Withdrawn

Glioblastoma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡